Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV was delisted on the 26th of May, 2020.
33 hedge funds and large institutions have $85.5M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2015 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 5 closing their positions.
114% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 7
25% more capital invested
Capital invested by funds: $68.3M → $85.5M (+$17.2M)
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
3% more funds holding
Funds holding: 32 → 33 (+1)
63% less call options, than puts
Call options by funds: $706K | Put options by funds: $1.91M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIS
AlphaOne Investment Services
West Chester,
Pennsylvania
|
+$4.95M |
| 2 |
Westfield Capital Management
Boston,
Massachusetts
|
+$4.82M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$4.05M |
| 4 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
+$1.94M |
| 5 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$1.77M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$2.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$728K |
| 3 |
Allianz Asset Management
Munich,
Germany
|
-$185K |
| 4 |
Goldman Sachs
New York
|
-$117K |
| 5 |
Renaissance Technologies
New York
|
-$50.9K |
CORV Hedge Fund Activity: Q2 2015 in Review
33 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q2 2015, worth a combined $85.5M — up 25% from $68.3M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new CORV positions and 5 closed out — a net gain of 1 holder — while 15 added to existing stakes and 7 trimmed.
The largest buyer was AlphaOne Investment Services, opening a new position worth an estimated $4.95M. The largest seller was Acuta Capital Partners, exiting entirely with an estimated $2.2M sold.
- 33 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q2 2015, up from 32 in Q1 2015.
- Funds reported $85.5M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q2 2015, up 25% quarter-over-quarter.
- 6 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q2 2015 and 5 closed out, a net change of +1 holder.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q2 2015 was AlphaOne Investment Services, an estimated $4.95M added.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q2 2015 was Acuta Capital Partners, an estimated $2.2M sold.
Based on aggregated 13F filings for Q2 2015.